Michael A. Jacobsen

2012 - Sarepta Therapeutics

In 2012, Michael A. Jacobsen earned a total compensation of $832K as Vice President, Finance at Sarepta Therapeutics, a 161% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$97,500
Option Awards$365,158
Salary$283,333
Stock Awards$75,600
Other$10,366
Total$831,957

Jacobsen received $365.2K in option awards, accounting for 44% of the total pay in 2012.

Jacobsen also received $97.5K in non-equity incentive plan, $283.3K in salary, $75.6K in stock awards and $10.4K in other compensation.

Rankings

In 2012, Michael A. Jacobsen's compensation ranked 6,859th out of 11,487 executives tracked by ExecPay. In other words, Jacobsen earned more than 40.3% of executives.

ClassificationRankingPercentile
All
6,859
out of 11,487
40th
Division
Manufacturing
2,457
out of 4,253
42nd
Major group
Chemicals And Allied Products
625
out of 1,203
48th
Industry group
Drugs
428
out of 925
54th
Industry
Pharmaceutical Preparations
334
out of 700
52nd
Source: SEC filing on April 30, 2013.

Jacobsen's colleagues

We found seven more compensation records of executives who worked with Michael A. Jacobsen at Sarepta Therapeutics in 2012.

2012

Sandesh Mahatme

Sarepta Therapeutics

Chief Financial Officer

2012

David Howton

Sarepta Therapeutics

General Counsel

2012

David Howton

Sarepta Therapeutics

General Counsel

2012

Christopher Garabedian

Sarepta Therapeutics

Chief Executive Officer

2012

Edward Kaye

Sarepta Therapeutics

Chief Executive Officer

2012

Jayant Aphale

Sarepta Therapeutics

Senior Vice President, Technical Operations

2012

Effie Toshav

Sarepta Therapeutics

General Counsel

News

You may also like